Surveillance of Tolerability And Treatment Efficacy of Wilate in von Willebrands disease: an observational study

Trial Profile

Surveillance of Tolerability And Treatment Efficacy of Wilate in von Willebrands disease: an observational study

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 11 May 2017

At a glance

  • Drugs Factor VIII/von Willebrand factor (Primary)
  • Indications Von Willebrand disease
  • Focus Adverse reactions
  • Acronyms Wilate-STATE
  • Sponsors Octapharma
  • Most Recent Events

    • 04 May 2017 Planned End Date changed from 30 May 2017 to 31 May 2020.
    • 06 Dec 2016 Results presented at the 58th Annual Meeting and Exposition of the American Society of Hematology
    • 12 Feb 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top